Expression of Concern: Comparative evaluation of isosorbide mononitrate and alendronate in management of postmenopausal osteoporosis

Arch Gynecol Obstet. 2023 Nov;308(5):1655. doi: 10.1007/s00404-023-07178-3.
No abstract available

Publication types

  • Expression of Concern